Myopathy and spontaneous Pasteurella pneumotropica-induced abscess formation in an HIV-1 transgenic mouse model

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue 2, 1996, Pages 101-116

  Dickie, Peter ^e   Mounts, Phoebe ^e   Purcell, Damian ^c   Miller, Georgina ^a   Fredrickson, Torgny ^b   Chang, Lung Ji ^e   Martin, Malcolm A ^d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e NONE

Author keywords

Abscess; HIV 1; Mouse model; Myopathy; Pasteurella pneumotropica

Indexed keywords

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; DNA SEQUENCE; GRAM NEGATIVE INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; MOLECULAR CLONING; MOUSE; MYOPATHY; NONHUMAN; PASTEURELLA; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALIA; BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; MUS MUSCULUS; NEGIBACTERIA; PASTEURELLA; PASTEURELLA PNEUMOTROPICA; RODENTIA;

EID: 0029841001     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199610010-00001     Document Type: Article

References (41)

1. Namikawa R, Kaneshima H, Lieberman M, Weissman IL, McCune JM. Infection of the SCID-hu mouse by HIV-1. Science 1988;242:1684-6.
2. Mosier DE, Gulizia RJ, Baird SM, Wilson DB, Spector DH, Spector SA. Human immunodeficiency virus infection of human-PBL-SCID mice. Science 1991;251:791-4.
3. Vogel J, Hinrichs SH, Reynolds RK, Luciw PA, Jay G. The HIV Tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988;335:606-11.
4. Khillan JS, Deen KC, Yu SH, Sweet RW, Rosenberg M, Westphal H. Gene transactivation mediated by the TAT gene of human immunodeficiency virus in transgenic mice. Nucleic Acids Res 1988;16:1423-30.
5. Leonard J, Khillan JS, Gendelman HE, et al. The human immunodeficiency virus long terminal repeat is preferentially expressed in Langerhans cells in transgenic mice. AIDS Res Hum Retroviruses 1989;5:421-30.
6. Leonard JH, Abramczuk JW, Pezen DS, et al. Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 1988;242:1665-70.
7. Dickie P, Felser J, Ekhaus M, Bryant J, Silver J, Marinos N, Notkins AL. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 1991;185:109-19.
8. Iwakura Y, Shioda T, Tosu M, Yoshida E, Hayashi M, Nagata T, Shibuta H. The induction of cataracts by HIV-1 in transgenic mice. AIDS 1992;6:1069-75.
9. Jolicoeur P, Laperrière A, Beaulieu N. Efficient production of human immunodeficiency virus proteins in transgenic mice. J Virol 1992;66:3904-8.
10. Thomas FP, Chalk C, Lalonde R, Robitaille Y, Jolicoeur P. Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J Virol 1994;68:7099-107.
11. Toggas SM, Masliah E, Rockenstein EM, Rail GF, Abraham CR, Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994;367:188-93.
12. Skowronski J, Parks D, Mariani R. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J 1993;12:703-13.
13. Brady HJM, Pennington DJ, Miles CG, Dzierzak EA. CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO J 1993;12:4923-32.
14. Lindemann D, Wilhelm R, Renard P, Althage A, Zinkernagel R, Mous J. Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3′-long terminal repeat transgene. J Exp Med 1994;179:797-807.
15. Keller G, Paige C, Gilboa E, Wagner EF. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent hematopoietic precursors. Nature 1985;318:149-54.
16. Lang RA, Metcalf D, Cuthbertson RA, et al. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 1987;51:675-86.
17. Leonard J, Parrott C, Buckler-White AJ, Turner W, Ross EK, Martin MA, Rabson AB. The NFκB binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J Virol 1989;63:4919-24.
18. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J Virol 1986;59:284-91.
19. Shinnick TM, Lerner RA, Sutcliff JG. Nucleotide sequence of Moloney murine leukemia virus. Nature 1981;293:543-8.
20. Chang L-J, McNulty E, Martin MA. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms. J Virol 1993;67:743-52.
21. Hogan B, Constantini F, Lacy E. Manipulating the mouse embryo: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1986.
22. Ahmad N, Venkatesan S. Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 1988;241:1481-5.
23. Muesing MA, Smith DH, Cabradilla CD, Benton CV, Lasky LA, Capon DJ. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature 1985;313:450-8.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
25. Harada S, Koyanagi Y, Nakashima H, Kobayashi N, Yamamoto N. Tumor promoter, TPA, enhances replication of HTLV-III/LAV. Virology 1986;154:249-58.
26. Willey RL, Smith D, Lasky L, et al. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 1988;62:139-47.
27. Finkelman FD, Schere I, Mond JJ, Kessler S, Kung JT, Metcalf ES. Polyclonal activation of the murine immune system by an antibody to IgD. II. Generation of polyclonal antibody production and cells with surface IgG. J Immunol 1982;129:638-46.
28. Cerny A, Merino R, Makino M, Waldvogel FA, Morse III HC, Izui S. Protective effect of cyclosporin A on immune abnormalities observed in the murine acquired immunodeficiency syndrome. Eur J Immunol 1991;21:1747-50.
29. Goroff DK, Holmes JM, Bazin H, Nisol F, Finkelman FD. Polyclonal activation of the murine immune system by an antibody to IgD. J Immunol 1991;146:18-25.
30. Levy JA, Cheng-Mayer C, Dina D, Luciw PA. AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts. Science 1986;232:998-1001.
31. Spector DH, Wade E, Wright DA, Koval V, Clark C, Jaquish D, Spector SA. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J Virol 1990;64:2298-308.
32. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986;47:333-48.
33. Dickie P, Gazzinelli RT, Chang L. Models of HIV-1 proviral gene expression wild type HIV and MLV/HIV transgenic mice. AIDS Res Hum Retroviruses (in press).
34. Gazzinelli RT, Sher A, Cheever A, Gerstberger S, Martin MA, Dickie P. Infection of HIV-1 transgenic mice with Toxoplasma gondii stimulates proviral transcription in macrophages in vivo. J Exp Med 1996;183:1645-56.
35. Wagner JE, Garrison RG, Johnson DR, McGuire TJ. Spontaneous conjunctivitis and dacryoadenitis of mice. J Am Vet Med Assoc 1969;155:1211-7.
36. Needham JR, Cooper JE. An eye infection in laboratory mice associated with Pasteurella pneumotropica. Lab Anim 1975;9:197-200.
37. Moore GJ, Aldred P. Treatment of Pasteurella pneumotropica abscesses in nude mice (nu/nu). Lab Anim 1978;12:227-8.
38. Moore GJ. Conjunctivitis in the nude rat. Lab Anim 1979;13:35.
39. Adams LD, Tomasselli AG, Robbins P, Moss B, Heinrikson RL. HIV-1 cleaves actin during acute infection of human T lymphocytes. AIDS Res Hum Retroviruses 1992;8:291-5.
40. Shoeman RL, Sachse C, Honor B, Mothes E, Kaufmann M, Traub P. Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Am J Pathol 1993;142:221-30.
41. Levy DN, Fernandes LS, Williams WV, Weiner DB. Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 1993;72:541-50.